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ABSTRACT 
Examination of Dioxin and Its Alteration of 
Gene expression via DNA Microarray Analysis. 
Justin Charles Wright 
Department of Veterinary Anatomy and Public Health 
Texas A8M University 
Fellows Advisor: Dr. David L. Busbee 
Department of Veterinary Anatomy and Public Health 
Endocrine disruptive chemicals are known to produce harmful developmental 
effects on humans and other animals. Since substantial quantities of these 
chemicals are concentrated in the fat reserves of their victims, it is reasonable to 
expect a correlation between chemical concentration and physical effect before 
and to research further into the actuality of the EDCs effects. Some health 
hazards that are suspected to result from chemical exposure in humans are cleft 
lip and palate problems, feminization of male offspring, extreme premature 
puberty in female offspring, neural tube defects, autism, ototoxity, fetal alcohol 
syndrome (FAS), fetal tobacco syndrome (FTS), Type II diabetes also known as 
Non Insulin Dependent Diabetes Mellitus (NIDDM), and ADD/ADHD. 
Little evidence has been available to demonstrate how dioxin specifically alters 
gene expression, both in developing embryos and adults. Recently, Texas A&M 
University has acquired several DNA Microarray Systems, which are 
revolutionizing the examination of research into gene expression alterations. 
A new cell line of human embryonic kidney cells (293T/17 epithelial) have been 
properly cultured, had the RNA successfully isolated, and patterns were 
interpreted for genetic change using DNA Microarray Analysis. Through a cDNA 
slide specifically spotted with DNA of approximately 1200 endocrine regulated 
genes, the RNA of these cells can be examined using the DNA Microarray 
System after being exposed to different concentrations of dioxin, estradiol, 
DMSO, combinations of chemicals, and finally a control line of unexposed cells. 
Specific altered genes of the human embryo are predicted to be represented as 
changed in the RNA of cells previously exposed to dioxin. A nearly undetectable 
amount of dioxin (10 M) was introduced to these cells and produced significant 
variation from the natural gene expression. These data suggest that major 
advances in the prevention of physical pain and deformities in both 
developmental and everyday lives of both humans and animals could be attained 
by reducing exposure to environmental chemicals. The genes that are altered by 
the effects of TCDD promise further research, investigation, and prevention of 
many disruptive diseases. 
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INTRODUCTION 
Over the past two decades, research has proven that endocrine disruptive 
chemicals (EDCs) such as the families of the polychlorinated biphenyls (PCBs), 
organochlorines (OCs), and substituted aromatic hydrocarbons (AHs) are 
becoming more prevalent as environmental pollutants. Even the most minute 
concentrations of EDCs are capable of changing both human and animal gene 
expression. Furthermore, other combinable chemical factors can make the 
determination of exactly how a particular gene is being altered quite difficult to 
discern (1). Normally chemicals are labeled endocrine disruptive chemicals 
(EDCs) because of their ability to bind to cellular receptors for steroid hormones. 
It is imperative for the proper hormone to bind to its designated receptor since 
the physiological development of both the fetal individual and the adult depend 
on it. Gene expression is directly correlated with the binding of hormones to 
their specific receptors (2-6, 18). People and animals worldwide are exposed to 
EDCs from many sources, which have the potential to bind to steroid receptors 
and thus skew the hormone-regulated process and thus alter gene expression. 
OBJECTIVE 
The goal of this research is to determine which genes, and to what degree these 
genes, are altered when they are exposed to TCDD (2, 3, 7, 8 tetrachlorodibenzo- 
The format is the in the style of the Journal of Endocrinology 
p-dioxin), more commonly known as dioxin. TCDD may be responsible for birth 
defects such as neural tube defects, autism, ototoxicity (toxicity to nerve supply 
of ear), feminization of male offspring, morphological abnormalities, precocious 
puberty (abnormal timing of pubescent stages), cleft palate, diabetes type II, 
possibly attention deficit disorder (ADD) I attention deficit hyperactive disorder 
(ADHD), and finally a decreased immune system function which this paper will 
emphasize (7, 8, 9-18). 
Aim 1: Learn to culture cells effectively and efficiently while watching over the 
safety of both the cells and personnel involved. 
Aim 2: Completely observe the analysis of the environmental contaminant 
dioxin using DNA microarray analysis. 
Aim 3: Determine degrees of alteration of gene expression by dioxin that is 
significant enough to alter the physiology of living cells. 
Aim 4: Derive from the data exactly which genes are altered most significantly 
with a focus on genes involved in the development of human embryos and 
immune system function. 
Hypothesis 1: Since TCDD is found where so many birth defects are taking 
place, the microarray will provide a much better understanding of the direct 
physiological changes that this chemical has on human life in vivo. 
Hypothesis 2: Human fetal cells exposed to dioxin will show a marked 
difference in gene expression in vitro. 
Hypothesis 3: Through evaluation using the array analyses, chemicals can be 
identified and reduced, then decrease, and thereafter will be prevented from 
further altering the lives of people. 
TCDD PROPERTIES 
Commonly called by the trade names dioxin and tetradioxin, TCDD (CizH4CI40& 
MW: 322) has a very simple planar structure, a normal white to colorless 
crystalline needle-like appearance, a melting point of 305-306 C, and has been 
labeled as a very toxic and dangerous chemical by the EPA. Dioxin is soluble in 
organic solvents, mildly in n-octanol, methanol, and lard oil, and insoluble in 
water. However, because of its extremely balanced structure it remains stable in 
water, acetone, 95'/o ethanol, and DMSO. Although TCDD will not ignite, when 
heated to 500'C or left under UV radiation, it will spontaneously degrade and 
thus its toxicity is abrogated (19, 20, 21). Except for unique cases such as 
natural fire from lightning, volcanoes, or seeping fossil fuels, dioxin for all 
practical purposes is not produced in large quantities naturally in the 
environment. The United States of America does not allow commercial 
production of TCDD within its borders but does allow laboratory production for 
experimental purposes only (21). Exposure to any amount of TCDD may lead to 
immediate toxicity and I or long-term detrimental defects (35). 
PROBLEMS WITH TCDD 
Historically, TCDD has been suspected to be a carcinogen In January of 2001, 
its classification by the EPA changed to a known carcinogen because of in-depth 
research and studies completed between TCDD exposure and neoplasm in 
humans. Not only has evidence of TCDD causing cancer in humans been 
shown but also in many different animals. Multiple species exposed can have 
both malignant and benign neoplasms in various sites and tissues throughout 
their body. Both sexes of mice, rats, and hamsters exposed to different amounts 
of TCDD in different ways have produced tumors: in the skin, gastrointestinal 
tract, and intraperitoneal area. These symptoms increase as the amount of 
exposure increases. Cancer in the hepatobiliary, lymphatic, adrenal cortex, 
nasal turbinates, skin, tongue, thyroid, and respiratory systems frequently occur 
after exposure to TCDD (22, 23). 
BIOACCUMULATION IN FAT 
Because of its relatively uniform structure and hydrophobicity (not water 
soluble), TCDD accumulates easily in fat, and is extremely resistant to 
biodegradation. Studies show that the biological half-life of TCDD in the fat of 
rodents is from 10 to 30 days while human TCDD retention has a half-life of 5. 8 
to 11. 3 years, presenting much more long-term exposure in humans. This 
simply means that being exposed at a chronic low-dose, human tissue 
accumulates TCDD much faster versus lab animals. It also implies that more 
genetic alteration would be expected in humans following extended exposure as 
compared to any experimental animal (24). TCDD has been found in the fat 
reserves of mammals exposed to pesticides, paper mills, effluents, diesel fumes, 
some herbicides, plasticizers, and bi-products of other chemical manufacturing. 
Dioxin bioaccumulates rapidly and metabolizes slowly, probably altering the 
gene expression of exposed mammals (25-27). 
SOURCES 
Common Exposure Sources 
TCDD can be exposed to the general public through ingestion, inhalation, and 
dermal contact. Dairy, meat, and fish products are important sources of dioxin 
exposure. Some common sources of dioxin are vacuum cleaner dust, car and 
room air filters, and clothes dryer lint (28). 
Combustion 
Since TCDD is a by-product of the manufacture of polychlorinated phenols, it 
has been detected in commercial samples of 2, 4, 5-trichlorophenol (2, 4, 5-TCP), 
pentachlorophenol (a wood preservative), and in the herbicide, 2, 4, 5- 
trichlorophenoxyacetic acid (2, 4, 5-T). Incineration of toxic (both industnal boilers 
and dedicated), municipal, and hospital waste, electrical transformer fires that 
are filled with PCBs, open burning of domestic waste, biogas combustion, pulp 
and paper-mill boilers, kraft black liquor recovery boilers, combustion of landfill 
gas, cement kilns (a. conventional fuels, b. hazardous waste), pulp and paper 
mill sludge incineration, lime kilns, asphalt mixing kilns, carbon reactivation, 
forest and brush fires, waste tire combustion, accidental fires, cigarette smoking, 
crematoria, candles, and kraft mill wood residue boilers all are sources for the 
by-product TCDD (29) 
Chemical Manufacturing 
A defoliant in the Vietnam War named Agent Orange contained a significant 
amount (2-30 ppm) of TCDD. A commonly used herbicide called Silvex, trade 
name for propionic acid, contains TCDD. When chlorine, chlorine dioxide, 
elemental chlorine, metal chlorides, sodium hypochlorite, bleaching pulp & paper 
mills, dioxazine dyes 8 pigments, alkylamine tetrachlorophenate, 
pentachlorophenol, phtalocyanine dyes and pigments, mono to 
tetrachlorophenols (1-4 Cls), chlorobenzenes, ethylene dichloride I vinyl, 
chloride monomer (EDCNCM), chloranil, tetrachlorobisphenol-A, 2, 4-D, 
polyvinyl chlonde (PVC), chlorinated pesticides, and printing inks are produced, 
TCDD will be a by-product (30). 
Power / Energy Generation 
Another source of dioxin is that of power and energy generation. Oil combustion 
is responsible for much of its production for industrial, utility, residential, and 
commercial purposes. Coal combustion, motor vehicle fuel combustion from 
leaded gasoline, unleaded gasonline, and diesel fuel, and finally wood 
combustion also contribute largely to the release of 2, 3, 7, 8 TCDD into our 
environment. It is important to realize that the sources given above are 
manifested through many forms and fashions. 
Metal Smelting / Refining 
Still another by-production source is the smelting of primary nonferrous metals, 
secondary nonferrous metals, magnesium, nickel, aluminum, copper, drum and 
barrel reclamation furnaces, lead, scrap electric wire recovery, iron and steel 
production, ore sintering, coke production, electric arc furnaces, and finally 
ferrous foundries (7). 
Reservoirs 
Tragically, TCDD has recently been found in sediments, soils, forests, landfills, 
pentachlorophenol-treated wood, and notably drinking water sources (31). 
CURRENT DIOXIN REGULATIONS IN THE U. S. 
TCDD is regulated as a toxic pollutant and hazardous waste by The 
Environmental Protection Agency (EPA) through the Safe Drinking Water Act 
(SDWA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Clean 
Water Act (CWA), and Toxic Substances Control Act (TSCA) to mention a few. 
Drinking water has a maximum contaminant level (MCL) set by the EPA at 3 x 
10 mg/L (32). 
TOXICITY 
Acute 
Much is known at this point about the acutely toxic physiological effects of high 
levels of EDCs that are found in fungicides, herbicides, pesticides, and some 
organochlorines (OC), both to humans and to laboratory animals (6-9). At high 
levels of exposure, an individual can expect to experience weight loss, liver 
damage, wasting of glands, malfunction of the immune system, loss of 
reproductive capabilities, increased incidence of cancer, skeletal abnormalities, 
altered sex determination, going through puberty extremely early or late, brain 
defects, and learning disabilities (33-37) Upon exposure to TCDD, common 
symptoms will include mild to extreme irritation of the respiratory tract, skin, and 
eyes (10, 38-40, 46). 
Chronic 
Not much is known about the continual exposure at low levels of EDC. 
Examples of continual exposure include surface level water sources and water 
contaminated with pesticides from agricultural pollutants (41). Research has 
proven that nursing offspring will have extremely high serum levels of EDC in 
their fat compared to the relatively minute amount that their mothers are 
exposed to. During their first year of life, infants in the United States will be 
exposed to 35-53 pg/kg body weight per day of TCDD equivalents through their 
mother's breast-fed milk (21, 45). The information about what these chemicals 
alter is extremely important especially since they are being transferred from 
mother to offspring at such disproportional quantities (36-37). Also proven is 
that the placental membrane is readily permeable to EDCs which will impact 
fetal cells exposed to them (42-44). 
METHODOLOGY AND PROCEDURES 
Cell Line 
A human fetal kidney cell line, specifically 293T/17, was purchased from 
American Type Culture Collection (ATCC). This cell line (Catalog No. CRL- 
11268) was transformed with adenovirus 5 DNA, was also transfected with SV40 
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large T antigen. These cells were deposited from Rockefeller University. Two 
advantages came from this cell line's properties, one being that it is an adherent 
cell line meaning that it is easily trypsinized, the other being that its morphology 
is epithelial which has not been thoroughly researched. 293T is very 
transfectable and comes from the 293 line which had the temperature sensitive 
SV40 T-antigen gene inserted into it. The seventeenth clone was selected by 
the depositor for its easy transfectability. 
Safety Level 
This was a Biosafety Level 2 contaminant 293T/17 had not been screened for 
human immunodeficiency viruses, Hepatitis B, or any other such diseases. 
Because of the risks listed above and to reduce risks of outside RNA, bacterial, 
fungal, or contamination of any other sort, all personnel wore latex gloves while 
handling 293T/17, and worked in a biological safety hood, level IIA (NuAire, 
Plymouth, MN). To further protection of the cell line, the minimum amount of 
disturbance that took place consisted of moving them from their incubator, to a 
microscope, and then directly to a UV treated sterile flow hood. Because UV 
light can alter gene expression, a fluorescent light available in the hood during 
interaction with the cells. 
11 
Thawing Cells 
Upon receipt, immediately the cells were brought out of cryopreservation. The 
vial was thawed in a 37'C water bath for two minutes and then sprayed down 
with 75'/0 isopropyl alcohol to avoid contamination of the outside of the vial. 
Media was warmed as well at 37'C for 15 minutes to allow for appropriate pH 
changes within the solution. The cells were then transferred to a Falcon (Becton 
Dickinson Franklin Lakes, NJ) 75cm' flask. 
Feeding Cells 
The 293T/17 cells were routinely observed via naked eye and microscope for 
opacity indicating bacterial contamination. Dubelco's Modified Eagle's Medium 
(Sigma St. Louis, MO) with 4mM L-glutamine which requires 4. 5g/L glucose, 
1. 5g/L sodium bicarbonate, and 10'/0 fetal bovine serum (FBS Atlanta 
Biologicals, Norcross, GA) was warmed in the water bath for 10 minutes while 
still being sealed for contamination with Para-film (Pechiney Plastic Packaging, 
Menasha, Wl). After correct temperature was achieved (37'C), 75'/0 isopropyl 
alcohol was applied to the outside of the bottle, the Para-film was removed, and 
the media was placed into the UV sterilized hood. Old media would be 
suctioned into a flask with a hose and sterile glass pipette. An electric pipetter, 
plastic sterile wrapped pipettes, and latex gloves were used for transferring 
either 10-15 mL of media into the 75cm' flasks or 20-25 mL of media into the 
150cm'flasks. The cells were then specifically allowed to grow in a 10'/0 CO2 air 
atmosphere @ 37 C in a humidified environment for anywhere from 1-3 days 
depending on conf luency. 
Subculturing 
It took 3 days before 90'/o conf luency was reached indicating the correct time for 
splitting the cell line. Later in the experiment, it decreased into 2 days and then 
into 1 day. New DMEM, phosphate buffer solution (PBS), and trypsin (AVTG) 
were warmed to 37 C for 10 minutes in the water bath. Isopropyl alcohol was 
applied to the outsides of the containers, the para-film was removed, and then 
was moved to the inside of the hood immediately. Upon splitting, since this is an 
adhesive cell line, the old media would be suctioned into a flask with a hose and 
sterile glass pipette. Five milliliters of PBS was added to the T — 75cm flask 
and 10 mL was added to the T — 150cm'. PBS was then removed immediately. 
Trypsin was added, 3 mL to the T — 75cm flask and 5. 5 mL to the T- 150cm ' 
which were then placed in the 10'/o CO~ air atmosphere at 37'C. Immediately 
after a period of 5 minutes of incubation, the flasks were placed into the hood 
and neutralized with 70 mL of DMEM for a 3-way split into the T — 150 
containers or 40 mL of DMEM for a 2-way split. For the T — 75 containers, 15 
mL of DMEM neutralized and were aliquotted for a 1:2 splitting and 25 mL for a 
1:3 splitting. The new passage number, date, cell hne, and persons working with 
the cells that day were recorded on the outside of each flask. Cells were then 
quickly returned to the same COz regulated incubator for further growth. 
Freezing Cells 
Dually, as both a safe-guard and as a relief from accumulating too many flasks 
from subculturing often, a perfectly sound practice is to freeze down cells in a 
cryopreservation technique. 293T/17 cells had their media removed, were 
washed with the standard amount of PBS, trypsinized, and then incubated — the 
middle two at the same times as used for subculturing. After trypsinization, cells 
were examined to see if they had lifted from their adhesion to the bottom of the 
flask, and were then transferred into a conical tube for centrifugation at 200X g 
for 10 minutes. Freezing media comprised of 20% fetal bovine serum (FBS) / 
10% dimethyl sulfoxide (DMSO) to complete media. After centnfugation was 
complete, media was removed and cells were resuspending from the pellet by 
gently thumping bottom of conical tube. For every 75cm of cell growth surface 
in the conical tube, 5 mL of freezing media was added to cells and then 
alloquatted in 1 mL segments into labeled cryotubes for -80'C freezer 
preservation. After a minimum of 4 hours in a Cryo Freezing Container by 
Nalgene, the cryotubes were then transferred to the liquid nitrogen tanks with 
their location recorded. 
RNA Isolation 
Isolation of RNA was conducted using the Totally RNA Kit (Ambion, Austin, TX) 
with a 15cc tube modification. Before beginning work on any samples, 
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everything was made RNAse-free by spraying Ambion's RNA Zap. Samples 
were then thawed on ice and centrifuged at 4 C. DNAse treatment then 
involved a second kit by Ambion, DNA Free Kit. The RNA concentration was 
then measured on a BioRad Ultraviolet Spectrophotometer. Then a 
1'ioagarose/formaldehyde gel was used for checking the integrity of the RNA 
isolated. A first and second strand of complimentary DNA was then 
synthesized. This was completed using the cDNA Synthesis Kit by Roche. After 
the double stranded cDNA synthesis, the residual RNA was digested. Ds-cDNA 
was then cleaned of RNAse I and Proteinase K by a careful phenol extraction. 
In order to produce RNA amplification and to label RNA probes, a protocol that 
generates dye-labeled antisense RNA probes for microarray hybridizations. 
Dye-containing solutions were protected from light with aluminum foil in order to 
prevent photo-bleaching. Ambion's Megascript T7 kit and arninoallyl-UTP was 
used for in vitro transcdiption. A protocol by Frank Wellmer in the Meyerowitz lab 
at Caltech was used for RNA generation, clean-up, and labeling. 
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CONCLUSIONS AND SUMMARY 
Conclusions 
Previously referred to as p27, Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B) 
which is down-regulated at locus 12p13, is attributed to the loss of 
heterozygosity (LOH) and also acute leukemia of the lymphoblast. Also labeled 
KIP1, this gene is responsible for tumor suppression (47). In order for CDKN1B 
to be activated and for cells to proliferate, cyclins must undergo phosphorylation 
by CAK. At normal levels of physiological ATP, cell proliferation will proceed 
normally, but at lower levels, cellular proliferation will cease (48). When there is 
not a substantial amount of CDKN1B to cooperate with Pten, then the body is 
much more susceptible to the development of prostate tumors (49, 50). Without 
CDKN1B, the body will not stop the proliferation of breast cancer cells (51). 
Neoplastic growth of the pituitary pars intermedia, ovulatory defect, and female 
sterility may occur should this gene be down-regulated (52). 
Studies show that deficiencies in the Kirsten rat sarcoma (KRAS2) often times 
are associated with colorectal cancer (53). Cells with KRAS2 mutations also 
had a link between endometrial cancers. Generally, more KRAS2 mutations will 
occur with aging (54). Previous studies show that cells that did not have 
substantial quantity of K-Ras could not form xenograft tumors, if they were 
placed with B-Raf. However, if there was substantial K-Ras, but there were 
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deletions for B-Raf, cells proved to be highly tumorigenic. This counters the 
previous idea that KRAS2 is solely responsible for tumor formation (55). 
Mutations such as those observed during this study in both of the oncogenes 
KRAS2 and neuroblastoma rat sarcoma (NRAS) are suspected to be linked to 
chronic myelomonocytic leukemia (56). Melanomas occur when a cell has 
deficiencies in NRAS (57). 
Another finding is that when retinoblastoma (RB1) is not expressed which is the 
case of this expenment, many of the head and neck squamous cells will form 
carcinomas leading to laryngeal cancer (58). When RAC1 is elevated, it will 
inhibit cell proliferation when needed. Thus it is reasonable to conclude that if 
RAC1 count is down, then cancers can result because nothing is directing it to 
terminate (59). 
Summary 
Endocrine disruptive chemicals are widespread, but as of yet there are neither 
ways to keep track of the actual exposures to different EDCs nor to be able to 
see the magnitude of the possible risks of the exposure. Because of the fact 
that these chemicals are being found in greater amounts in the liver, serum, 
milk, and fat of humans and animals (33) and also because of the increasing 
direct correlation of exposure to EDCs and their adverse health effects (34), this 
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topic has been exceedingly research-worthy. The hope that this research brings 
is that the culprit chemicals responsible for the increasingly brutal morphological 
abnormalities will be discovered and dealt with to the benefit and future of 
human and animal postenty. 
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